New SSRIs & Mood Therapies treatments in trials

Sertraline, Escitalopram, Fluoxetine — major depression & anxiety disorders. Track the treatments still in clinical testing and see which are closest to an FDA decision.

62Closest to approval (Phase 3)

148Mid-stage (Phase 2)

47Early stage (Phase 1)

1,433Total recruiting

In one line

1,433 ssris & mood therapies trials are recruiting right now, 62 of them in Phase 3 — the stage immediately before an FDA decision.

Recruiting now

Twelve of the currently recruiting studies. Open one for a plain-English summary of who it is for and what it involves.

NCT06748209Phase 4RecruitingEstablishing Mobile Transcranial Magnetic StimulationSponsorMedical University of South CarolinaEnrolling30Summary NCT07458100NARecruitingThe STEP-MIED Trial: Digital Stepped-Care for Emotional DisordersSponsorPeking UniversityEnrolling464Summary NCT06777563NARecruitingEMA and mHealth in Preventing Postpartum DepressionSponsorThe University of Hong KongEnrolling60Summary NCT06524830Phase 2RecruitingA Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)Sponsoratai Therapeutics, Inc.Enrolling142Summary NCT05703711NARecruitingCombining mHealth and Nurse-delivered Care to Improve the Outcomes of People With Serious Mental Illness in West AfricaSponsorUniversity of WashingtonEnrolling360Summary NCT06374277NARecruitingPharmacy-led Transitions of Care Intervention to Improve Medication AdherenceSponsorUniversity of TennesseeEnrolling388Summary NCT06636357Phase 2RecruitingNitrous Oxide in the Treatment of Acute Suicidal IdeationSponsorUniversity of ZurichEnrolling85Summary NCT05917119NARecruitingBright Light Therapy for OSASponsorVA Office of Research and DevelopmentEnrolling60Summary NCT06828887Phase 2RecruitingDose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDDSponsorVigonvita Life SciencesEnrolling400Summary NCT03276793NARecruitingBrain Connectivity in DepressionSponsorBrigham and Women's HospitalEnrolling260Summary NCT05457465Phase 2RecruitingAssessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar DisorderSponsorMclean HospitalEnrolling25Summary NCT06342011NARecruitingEffect of Anti-inflammatory Diet in Patients With Inflammatory Bowel DiseaseSponsorThe Fourth Affiliated Hospital of Zhejiang University School of MedicineEnrolling88Summary

View all 1,433 on ClinicalTrials.gov

Already approved for this area

SSRIs & Antidepressants

Zoloft, Lexapro, Prozac, Celexa — approved products with their NDC records and billing codes.

Open the class

Every NDC in this class

The FDA registry filtered to ssris & antidepressants, with packaging and 11-digit billing conversions.

Search the directory

Loading the trial explorer…